AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

InsuQuick VDPen

Prescription Icon
Prescription Required

Marketer

USV Ltd

Salt Composition

Insulin Aspart (100u/ml)

Overview InsuQuick VDPen

Diabetics with type 1 or 2 mellitus utilize InsuQuick VDPen for glycemic management. This rapid-acting insulin lowers post-prandial glucose, mitigating the risk of severe diabetic complications. InsuQuick VDPen is typically combined with a long-acting insulin or other antidiabetic agents. Administered subcutaneously, its application should be timed to coincide with meal initiation or within 20 minutes thereafter. Regular blood glucose monitoring and result reporting to your physician are crucial for accurate dosage determination. Avoid use during hypoglycemia. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or cardiac conditions. Pregnant or lactating individuals require physician consultation for potential dosage adjustments. Discontinuation should only occur under medical supervision. Successful treatment requires adherence to a comprehensive program including dietary modifications, regular exercise, and weight management as recommended by your healthcare provider. Common adverse effects include hypoglycemia, headache, nasopharyngitis, and upper respiratory infections; these are minimized through accurate dosing, consistent mealtimes, and diligent blood glucose monitoring. Excessive alcohol consumption can exacerbate hypoglycemia. Additional side effects may encompass injection site reactions such as erythema, edema, or lipodystrophy. Weight gain is a potential consequence for some users.

Primary Ingredients of InsuQuick VDPen

No text provided to rephrase.

Uses of InsuQuick VDPen

Managing Diabetes

Major Benefits of InsuQuick VDPen:

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of InsuQuick VDPen:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Upper respiratory tract infection

How to use InsuQuick VDPen:

A healthcare professional will instruct you on the proper administration of this medication.

How InsuQuick VDPen works:

InsuQuick VDPen, a rapid-acting insulin analog, initiates its effect within 10 to 20 minutes of administration. Mimicking the function of endogenous insulin, it promotes glucose absorption into muscle and adipose tissue while concurrently suppressing hepatic glucose production.

SAFETY ADVICE

What if you forget to take InsuQuick VDPen :

Delayed administration of InsuQuick VDPen may lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust your subsequent dose as needed.

Facts to Know About InsuQuick VDPen

LabelValue
Chemical Type Modified insulin
Developing Habits No.
Treatment Category Diabetes Management
Behavior Class Fast-acting insulin analogs

FAQs on InsuQuick VDPen

InsuQuick VDPen, an insulin analog, is an anti-diabetic medication for adults and children aged 2 and older. It's prescribed to manage blood sugar and improve glycemic control.
InsuQuick VDPen delivers rapid-acting, synthetic human insulin. Manufactured using recombinant DNA technology, it employs *Saccharomyces cerevisiae* to produce insulin aspart. This sterile, clear, colorless solution contains insulin aspart, glycerin, phenol, metacresol, zinc, sodium chloride, and other components.
InsuQuick VDPen dosage is individualized. Always follow your doctor's instructions for regular use. It's typically combined with intermediate- or long-acting insulin and injected subcutaneously 5-10 minutes before a meal, or immediately afterward. Eat a meal or snack within 10 minutes of injection to prevent hypoglycemia.
Yes, InsuQuick VDPen can cause weight gain, whether used independently or with other insulin treatments. This is a frequent side effect. Weight gain results from reduced glucose excretion in urine and the insulin's anabolic effects, promoting fat and protein buildup. Discuss this with your doctor to determine the cause and appropriate management.
Type 1 diabetes requires lifelong InsuQuick VDPen treatment because the body doesn't produce enough insulin. Type 2 diabetes patients, however, may discontinue InsuQuick VDPen if their blood sugar is well-managed through diet, exercise, and oral medications.
InsuQuick VDPen can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always keep readily available fast-acting glucose sources, such as sugary sweets, glucose biscuits, or fruit juice, on hand.
InsuQuick VDPen is a rapid-acting insulin for managing blood sugar in people with diabetes. Its quick onset compared to regular insulin helps control post-meal glucose spikes. Administer it subcutaneously 5–10 minutes before meals; if a dose is missed, it can be injected afterward.
InsuQuick VDPen is safe for pregnant women when prescribed and monitored by a doctor. Your doctor may adjust your dosage and recommend increased blood glucose monitoring. Consult your physician if you are pregnant, or plan to become pregnant, while using InsuQuick VDPen.
InsuQuick VDPen
914
MRP 1,007
9% off